mRNA Encoded Antibodies
•
0 likes•3 views
As a transient carrier of information, exogenous mRNA is considered to be a powerful tool to guide a body to produce its own therapeutics. Based on the structural elements of the mRNA, which have an impact on its performance, including potential immunogenicity, efficacy of translation and stability of the molecule. Nowadays, several studies have showed that antibody-encoding, sequence-optimized or unmodified mRNA in LNPs empowered mice model to successfully fight a variety of biological threats, such as toxins, viruses, and tumors, which indicates that mRNA encoded antibodies will have great potential in therapeutic fields, such as cancer, infectious diseases areas.https://www.creativebiolabs.net/mrna-encoded-antibodies_83.htm
Report
Share
Report
Share
Download to read offline
Recommended
Microbial production of recombinant pharmaceuticals
This document summarizes trends in recombinant pharmaceutical production from microbial cells. Around 650 protein drugs have been approved worldwide, with about 400 produced through recombinant technologies. An additional 1300 are under development. Production has expanded beyond early use of E. coli to include yeast, insect, and mammalian cells which provide proper post-translational modifications. Emerging systems aim to improve protein functionality while maintaining simplicity of prokaryotic culture. Recombinant drugs now target a wide range of diseases, led by metabolic, hematological, and cancer applications.
Animal cell culture in Biopharmaceutical Industry in the Production of Therap...
This presentation will help you to understand the basics of Animal cell culture along with its applicability in the diagnosis and treatment of cancer, and autoimmune diseases.
Biotechnology in livestock improvement
Livestock sector is an important sector in indian economy. To boost the productive performance of existing livestock population in india, biotechnolgy plays a key role to fullfill this.
Production of-secondary-metabolites
Plant tissue culture is used to produce valuable secondary metabolites. There are three main methods: cell suspension cultures, hairy root cultures, and immobilized cell cultures. Cell suspension cultures are the most common. They involve transferring plant cells or callus to liquid medium to grow as a suspension. Medium components, regulators, precursors, elicitors, and environmental factors can be manipulated to enhance metabolite production. Hairy root cultures use plant cells transformed by bacteria to produce root-like structures that also synthesize metabolites. Immobilized cell cultures entrap or affix cells to allow contact while protecting from shear stress. Each method aims to produce metabolites through optimized bioprocessing conditions at large scales.
The cell line integrity
The cell lines used to manufacture biopharmaceuticals must meet strict quality criteria to ensure high-quality, stable products. Master cell banks are critical starting materials, and should be sterile, mycoplasma-free, and tested for identity and purity. Cell lines must stably express the drug with high productivity, appropriate quality and structure, and be robust enough for large-scale production. Comprehensive testing of cell lines and banks is required by guidelines to confirm identity, purity, freedom from contamination, and genetic stability.
Animal cell introduction
This presentation will help to understand the basics of mammalian cell culture. I have also covered the difference between adherent and suspension cell lines. I have also included the advantages and disadvantages of the cell line.
The cell line integrity
1) Cell lines used for manufacturing biopharmaceuticals must meet strict quality criteria to ensure high quality, stable production. This includes being capable of high productivity, producing molecules with the appropriate structure and quality, and accepting and stably expressing foreign DNA.
2) Master cell banks are critical starting materials that are extensively tested for sterility, mycoplasma, and adventitious agents to ensure safety.
3) Routine monitoring of cell line integrity and performance during biomanufacturing helps evaluate the process and cell line stability over time.
Applications of cell lines
A cell line is a product of immortal cells that are used for biological research.
Cells used for cell lines are immortal, that happens if a cell is cancerous.
The cells can perpetuate division indefinitely which is unlike regular cells which can only divide approximately 50 times.
Human cell lines
MCF-7 breast cancer
HL 60 Leukemia
HEK-293 Human embryonic kidney
HeLa Henrietta lacks
Primate cell lines
Vero African green monkey kidney epithelial cells
Cos-7 African green monkey kidney cells
And others such as CHO from hamster, sf9 & sf21 from insect cells.
Recommended
Microbial production of recombinant pharmaceuticals
This document summarizes trends in recombinant pharmaceutical production from microbial cells. Around 650 protein drugs have been approved worldwide, with about 400 produced through recombinant technologies. An additional 1300 are under development. Production has expanded beyond early use of E. coli to include yeast, insect, and mammalian cells which provide proper post-translational modifications. Emerging systems aim to improve protein functionality while maintaining simplicity of prokaryotic culture. Recombinant drugs now target a wide range of diseases, led by metabolic, hematological, and cancer applications.
Animal cell culture in Biopharmaceutical Industry in the Production of Therap...
This presentation will help you to understand the basics of Animal cell culture along with its applicability in the diagnosis and treatment of cancer, and autoimmune diseases.
Biotechnology in livestock improvement
Livestock sector is an important sector in indian economy. To boost the productive performance of existing livestock population in india, biotechnolgy plays a key role to fullfill this.
Production of-secondary-metabolites
Plant tissue culture is used to produce valuable secondary metabolites. There are three main methods: cell suspension cultures, hairy root cultures, and immobilized cell cultures. Cell suspension cultures are the most common. They involve transferring plant cells or callus to liquid medium to grow as a suspension. Medium components, regulators, precursors, elicitors, and environmental factors can be manipulated to enhance metabolite production. Hairy root cultures use plant cells transformed by bacteria to produce root-like structures that also synthesize metabolites. Immobilized cell cultures entrap or affix cells to allow contact while protecting from shear stress. Each method aims to produce metabolites through optimized bioprocessing conditions at large scales.
The cell line integrity
The cell lines used to manufacture biopharmaceuticals must meet strict quality criteria to ensure high-quality, stable products. Master cell banks are critical starting materials, and should be sterile, mycoplasma-free, and tested for identity and purity. Cell lines must stably express the drug with high productivity, appropriate quality and structure, and be robust enough for large-scale production. Comprehensive testing of cell lines and banks is required by guidelines to confirm identity, purity, freedom from contamination, and genetic stability.
Animal cell introduction
This presentation will help to understand the basics of mammalian cell culture. I have also covered the difference between adherent and suspension cell lines. I have also included the advantages and disadvantages of the cell line.
The cell line integrity
1) Cell lines used for manufacturing biopharmaceuticals must meet strict quality criteria to ensure high quality, stable production. This includes being capable of high productivity, producing molecules with the appropriate structure and quality, and accepting and stably expressing foreign DNA.
2) Master cell banks are critical starting materials that are extensively tested for sterility, mycoplasma, and adventitious agents to ensure safety.
3) Routine monitoring of cell line integrity and performance during biomanufacturing helps evaluate the process and cell line stability over time.
Applications of cell lines
A cell line is a product of immortal cells that are used for biological research.
Cells used for cell lines are immortal, that happens if a cell is cancerous.
The cells can perpetuate division indefinitely which is unlike regular cells which can only divide approximately 50 times.
Human cell lines
MCF-7 breast cancer
HL 60 Leukemia
HEK-293 Human embryonic kidney
HeLa Henrietta lacks
Primate cell lines
Vero African green monkey kidney epithelial cells
Cos-7 African green monkey kidney cells
And others such as CHO from hamster, sf9 & sf21 from insect cells.
Plant metabolite engineering
This document discusses plant metabolic engineering. It begins with an introduction to metabolic engineering and explains that it involves modifying biochemical reactions or introducing new ones using recombinant DNA to direct the formation of products or modify cellular properties. It then discusses plants as natural factories for metabolic engineering due to their low cost and ease of growth. Various strategies for plant metabolic engineering are covered, including modifying rate limiting steps or diverting flux. Applications like producing antibodies, edible vaccines, polymers and pharmaceuticals in plants are also summarized. Emerging technologies and the future of the field are then outlined.
Biotech 2019 - Leveraging Advances in Industrial Biotechnology in the Cellula...
The utilization of animal stem cells to grow muscle and fat tissues in vitro for consumption, dubbed “cell-based meat,” offers an unprecedented opportunity to transform animal agriculture and produce meat in a humane and sustainable way. This nascent, interdisciplinary industry intersects cell biology, tissue engineering, biochemical engineering, and food science, with tangential impacts on issues relating to environmental science, human health, and regulatory policies. This talk will provide an industry snapshot and highlight the current challenges to scaling cell-based meat production, focusing on the needs and opportunities for industrial biotechnology to participate in the development of new tools, resources, or optimizations required to reach price parity with traditional animal meat. Finally, applications for industrial biotechnology in the broader "cellular agriculture" fields will be discussed.
Practical 4 07
The document discusses different types of cell cultures, including primary cultures derived from animal tissue, continuous cultures comprised of cell lines, and normal diploid cells with a finite lifespan. It describes common cell lines used in research, including HeLa cells from cervical carcinoma and CHO cells from hamster ovary. The key components of maintaining cell cultures are discussed, such as temperature, atmosphere, sterile conditions, culture medium, and growth equipment. Tasks demonstrate observing cell morphology, quantifying cell density using a hemocytometer, and counting chromosomes in CHO cells, which are shown to have an aneuploid number due to long-term cultivation.
Arsh copy
Cell lines are immortal cell cultures that are used extensively in biomedical research. Some key uses of cell lines include studying basic cell biology, testing drug toxicity, cancer research, virology studies, and gene therapy. Common cell lines include HeLa cells from cervical cancer tissue and MCF-7 cells from breast cancer tissue. Cell lines are also important in the production of vaccines, antibodies, and other biological products through recombinant protein expression in cultured cells. Respiratory and pancreatic beta cell lines have applications in research on inflammation, diabetes, and other diseases.
Application of cell line
Cell lines are immortal cell cultures that are used extensively in biomedical research. Some key uses of cell lines include modeling disease and testing drug toxicity. Common cell lines include HeLa cells, MCF-7 breast cancer cells, and VERO monkey kidney cells. Cell lines are also used to produce biological products like vaccines, antibodies, and recombinant proteins. Respiratory cell lines help study lung diseases while pancreatic beta cell lines aid diabetes research. The duck cell line EB66 is being used commercially for viral vaccine production.
Expression systems
The document discusses different host systems for producing recombinant proteins, including prokaryotic and eukaryotic systems. It focuses on the bacterial expression system Escherichia coli (E. coli) as a widely used prokaryotic host. While E. coli allows high levels of recombinant protein expression at low cost, it has limitations such as a lack of post-translational modifications and improper protein folding. Recent research has shown some success in secreting recombinant proteins from E. coli to circumvent some of these limitations. The document examines advantages and challenges of various host systems for recombinant protein production.
Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...
This document discusses host cell proteins (HCPs) that are present during the production of recombinant proteins like monoclonal antibodies using Chinese hamster ovary (CHO) cells. It notes that while HCP removal is important, the identity and dynamics of HCPs during cell culture and downstream processing are largely unknown. The document summarizes recent research that has begun to identify HCPs present and track their dynamics during fermentation and purification. It discusses how understanding HCP profiles could enable more rational engineering of cell lines and processing steps to better remove problematic HCPs.
High-performing CHO cell lines
Celonic has developed a cell line development platform to generate high-level expression cell lines for biologics. Their platform utilizes CHO-K1 cells adapted for suspension culture and growth in chemically defined media. After cloning and transfection of stable pools, early screening in fed-batch experiments selects for optimal clones based on productivity and quality attributes. This enables selection of the best clones for further process development, scale-up, and industrial production exceeding titers of 7 g/L. Celonic offers access to their platform and GMP banked CHO-K1 cell line to develop high performing cell lines for biomanufacturing.
Hormone and Enzyme (Description and synthesis)
This lecture discusses five major groups of products that can be obtained through fermentation: biomass, enzymes/hormones, metabolites, recombinant products, and transformation products. It provides examples of specific microbial products including baker's yeast, single-cell protein for food, and the enzyme pectinase produced by Aspergillus niger to clarify fruit juices. The lecture also covers the production of industrial enzymes from microbes through fermentation and genetic engineering techniques.
BIOMIMESYS® Oncology
BIOMIMESYS is an innovative hydrogel scaffold produced by HCS Pharma for 3D cell culture. It is made of hyaluronic acid and collagen, which mimic the extracellular matrix. Cells cultured in BIOMIMESYS form structures that closely resemble in vivo conditions. This allows cells to be studied under more physiologically relevant conditions for applications in drug development, metabolic studies, and cancer research. BIOMIMESYS is an easy to use, ready-to-use product suitable for various downstream applications and analysis techniques. It has been successfully used with many cancer cell lines.
Animal cell culture
The document provides information about animal cell culture. It discusses the requirements for culturing cells such as temperature, media, growth factors, and culture environments including pH, osmolality, and buffering. It describes the growth cycle of cells including the lag, log and plateau phases. The document outlines the basic equipment used in cell culture like incubators, laminar flow hoods, refrigerators, and microscopes. It discusses primary and secondary cell cultures, monolayer and suspension cultures, and finite versus continuous cell lines. Applications of animal cell culture mentioned include model systems, toxicity testing, cancer research, virology, and cell-based manufacturing.
Development and strategies of cell-culture technology for influenza vaccine [...
This document discusses strategies for improving cell culture technology for influenza vaccine production. It outlines the development of cell lines like MDCK and PER.C6 that are used for large-scale vaccine production. Reasons for low viral yields in cell culture include low cell density, cell death, and strains not growing well. Strategies to improve yields include manipulating the cell line, virus strain, infection conditions, and culture conditions to optimize cell survival and virus replication. The goal is to establish robust and scalable cell culture processes for purer and faster influenza vaccine production compared to egg-based methods.
Hybridoma Technology & its application in fisheries
The document discusses the process of producing monoclonal antibodies through hybridoma technology. It involves fusing antibody-producing B-lymphocytes with myeloma tumor cells to create a hybrid cell that can divide indefinitely and produce antibodies of a single specificity. The process includes immunizing mice, fusing their spleen cells with tumor cells, selecting antibody-producing hybridomas through HAT medium, and harvesting monoclonal antibodies through in vitro or in vivo methods for various medical applications. While this technology has improved disease diagnosis and treatment, it remains inefficient and labor-intensive.
Applications of animal biotechnology
The document discusses various applications of animal biotechnology including transgenic animals, biopharming, and stem cells. It provides details on using transgenic mice, livestock, fish, and other animals to produce pharmaceuticals like growth factors, hormones, and clotting factors. Stem cells are discussed for their role in disease treatment, drug testing, and therapeutic cloning applications.
Applications of Plant Tissue Culture
I have discussed Applications of Plant Tissue Culture under the following subheadings,
1. Micro Propagation
2. Clonal Propagation
3. Production of Genetically Variable Plants
4. Production of Virus Free Plants
5. Plant Breeding
6. Production of Useful Biochemicals
7. Preservation of Plant Genetic Resources
8. Importance of Tissue Culture in Biotechnology
Savannah Neu_Senior Design Problem Statement
Immucor, a biotechnology company, is experiencing decreases in the quality and quantity of HLA protein produced from their B cell culture process. They have asked the A-Team to identify the root cause of this production problem and propose solutions to increase HLA and B cell yield. The A-Team envisions redesigning cell culture protocols, constructing a system to monitor cell growth in real-time, and implementing new organization systems to promote continuous improvement. Their proposed solution involves characterizing the B cell lines, analyzing current production systems, and collecting data on cell health and growth variables to quantify HLA protein production, staying within a $3,000 cost.
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
This presentation gives an insight into the mammalian cell being used as an expression system, it also includes a brief introduction to the strong promoters.
Production system of biologics
This presentation deals with different types of production system like bacterial,insect,fungal,animal etc.
04 panel05
Molecular pharming uses transgenic animals and plants to produce pharmaceutical proteins. Genes coding for desired proteins are inserted into farm animals so the proteins are expressed in their milk in a continual manner. While transgenic plants are cheap to maintain and easy to propagate, continually harvesting proteins from plants is difficult. The transgenic rubber tree combines advantages of animals and plants by allowing for continual tapping of latex without damage, providing sustained protein production at low cost. Successful molecular pharming still faces challenges in scaling production and ensuring proper protein folding and post-translational modification. The feasibility will depend on matching or improving costs compared to microbial bioreactor production.
Cell lines and maintanence
It contains cell lines and its types and topmost cell lines and criteria for the selection of cell lines
ADC conjugate sites analysis
Antibody-drug conjugates employ the specific monoclonal antibodies (mAbs) to achieve targeted delivery of the conjugated cytotoxic molecules to tumor cells.
https://www.creative-biolabs.com/adc/conjugate-sites-analysis.htm
adc chemistry
As one major component of an antibody-drug conjugate (ADC), the antibody is the key for target specificity and serves as the cargo to deliver the cytotoxic drug (payload).
https://www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm
More Related Content
Similar to mRNA Encoded Antibodies
Plant metabolite engineering
This document discusses plant metabolic engineering. It begins with an introduction to metabolic engineering and explains that it involves modifying biochemical reactions or introducing new ones using recombinant DNA to direct the formation of products or modify cellular properties. It then discusses plants as natural factories for metabolic engineering due to their low cost and ease of growth. Various strategies for plant metabolic engineering are covered, including modifying rate limiting steps or diverting flux. Applications like producing antibodies, edible vaccines, polymers and pharmaceuticals in plants are also summarized. Emerging technologies and the future of the field are then outlined.
Biotech 2019 - Leveraging Advances in Industrial Biotechnology in the Cellula...
The utilization of animal stem cells to grow muscle and fat tissues in vitro for consumption, dubbed “cell-based meat,” offers an unprecedented opportunity to transform animal agriculture and produce meat in a humane and sustainable way. This nascent, interdisciplinary industry intersects cell biology, tissue engineering, biochemical engineering, and food science, with tangential impacts on issues relating to environmental science, human health, and regulatory policies. This talk will provide an industry snapshot and highlight the current challenges to scaling cell-based meat production, focusing on the needs and opportunities for industrial biotechnology to participate in the development of new tools, resources, or optimizations required to reach price parity with traditional animal meat. Finally, applications for industrial biotechnology in the broader "cellular agriculture" fields will be discussed.
Practical 4 07
The document discusses different types of cell cultures, including primary cultures derived from animal tissue, continuous cultures comprised of cell lines, and normal diploid cells with a finite lifespan. It describes common cell lines used in research, including HeLa cells from cervical carcinoma and CHO cells from hamster ovary. The key components of maintaining cell cultures are discussed, such as temperature, atmosphere, sterile conditions, culture medium, and growth equipment. Tasks demonstrate observing cell morphology, quantifying cell density using a hemocytometer, and counting chromosomes in CHO cells, which are shown to have an aneuploid number due to long-term cultivation.
Arsh copy
Cell lines are immortal cell cultures that are used extensively in biomedical research. Some key uses of cell lines include studying basic cell biology, testing drug toxicity, cancer research, virology studies, and gene therapy. Common cell lines include HeLa cells from cervical cancer tissue and MCF-7 cells from breast cancer tissue. Cell lines are also important in the production of vaccines, antibodies, and other biological products through recombinant protein expression in cultured cells. Respiratory and pancreatic beta cell lines have applications in research on inflammation, diabetes, and other diseases.
Application of cell line
Cell lines are immortal cell cultures that are used extensively in biomedical research. Some key uses of cell lines include modeling disease and testing drug toxicity. Common cell lines include HeLa cells, MCF-7 breast cancer cells, and VERO monkey kidney cells. Cell lines are also used to produce biological products like vaccines, antibodies, and recombinant proteins. Respiratory cell lines help study lung diseases while pancreatic beta cell lines aid diabetes research. The duck cell line EB66 is being used commercially for viral vaccine production.
Expression systems
The document discusses different host systems for producing recombinant proteins, including prokaryotic and eukaryotic systems. It focuses on the bacterial expression system Escherichia coli (E. coli) as a widely used prokaryotic host. While E. coli allows high levels of recombinant protein expression at low cost, it has limitations such as a lack of post-translational modifications and improper protein folding. Recent research has shown some success in secreting recombinant proteins from E. coli to circumvent some of these limitations. The document examines advantages and challenges of various host systems for recombinant protein production.
Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...
This document discusses host cell proteins (HCPs) that are present during the production of recombinant proteins like monoclonal antibodies using Chinese hamster ovary (CHO) cells. It notes that while HCP removal is important, the identity and dynamics of HCPs during cell culture and downstream processing are largely unknown. The document summarizes recent research that has begun to identify HCPs present and track their dynamics during fermentation and purification. It discusses how understanding HCP profiles could enable more rational engineering of cell lines and processing steps to better remove problematic HCPs.
High-performing CHO cell lines
Celonic has developed a cell line development platform to generate high-level expression cell lines for biologics. Their platform utilizes CHO-K1 cells adapted for suspension culture and growth in chemically defined media. After cloning and transfection of stable pools, early screening in fed-batch experiments selects for optimal clones based on productivity and quality attributes. This enables selection of the best clones for further process development, scale-up, and industrial production exceeding titers of 7 g/L. Celonic offers access to their platform and GMP banked CHO-K1 cell line to develop high performing cell lines for biomanufacturing.
Hormone and Enzyme (Description and synthesis)
This lecture discusses five major groups of products that can be obtained through fermentation: biomass, enzymes/hormones, metabolites, recombinant products, and transformation products. It provides examples of specific microbial products including baker's yeast, single-cell protein for food, and the enzyme pectinase produced by Aspergillus niger to clarify fruit juices. The lecture also covers the production of industrial enzymes from microbes through fermentation and genetic engineering techniques.
BIOMIMESYS® Oncology
BIOMIMESYS is an innovative hydrogel scaffold produced by HCS Pharma for 3D cell culture. It is made of hyaluronic acid and collagen, which mimic the extracellular matrix. Cells cultured in BIOMIMESYS form structures that closely resemble in vivo conditions. This allows cells to be studied under more physiologically relevant conditions for applications in drug development, metabolic studies, and cancer research. BIOMIMESYS is an easy to use, ready-to-use product suitable for various downstream applications and analysis techniques. It has been successfully used with many cancer cell lines.
Animal cell culture
The document provides information about animal cell culture. It discusses the requirements for culturing cells such as temperature, media, growth factors, and culture environments including pH, osmolality, and buffering. It describes the growth cycle of cells including the lag, log and plateau phases. The document outlines the basic equipment used in cell culture like incubators, laminar flow hoods, refrigerators, and microscopes. It discusses primary and secondary cell cultures, monolayer and suspension cultures, and finite versus continuous cell lines. Applications of animal cell culture mentioned include model systems, toxicity testing, cancer research, virology, and cell-based manufacturing.
Development and strategies of cell-culture technology for influenza vaccine [...
This document discusses strategies for improving cell culture technology for influenza vaccine production. It outlines the development of cell lines like MDCK and PER.C6 that are used for large-scale vaccine production. Reasons for low viral yields in cell culture include low cell density, cell death, and strains not growing well. Strategies to improve yields include manipulating the cell line, virus strain, infection conditions, and culture conditions to optimize cell survival and virus replication. The goal is to establish robust and scalable cell culture processes for purer and faster influenza vaccine production compared to egg-based methods.
Hybridoma Technology & its application in fisheries
The document discusses the process of producing monoclonal antibodies through hybridoma technology. It involves fusing antibody-producing B-lymphocytes with myeloma tumor cells to create a hybrid cell that can divide indefinitely and produce antibodies of a single specificity. The process includes immunizing mice, fusing their spleen cells with tumor cells, selecting antibody-producing hybridomas through HAT medium, and harvesting monoclonal antibodies through in vitro or in vivo methods for various medical applications. While this technology has improved disease diagnosis and treatment, it remains inefficient and labor-intensive.
Applications of animal biotechnology
The document discusses various applications of animal biotechnology including transgenic animals, biopharming, and stem cells. It provides details on using transgenic mice, livestock, fish, and other animals to produce pharmaceuticals like growth factors, hormones, and clotting factors. Stem cells are discussed for their role in disease treatment, drug testing, and therapeutic cloning applications.
Applications of Plant Tissue Culture
I have discussed Applications of Plant Tissue Culture under the following subheadings,
1. Micro Propagation
2. Clonal Propagation
3. Production of Genetically Variable Plants
4. Production of Virus Free Plants
5. Plant Breeding
6. Production of Useful Biochemicals
7. Preservation of Plant Genetic Resources
8. Importance of Tissue Culture in Biotechnology
Savannah Neu_Senior Design Problem Statement
Immucor, a biotechnology company, is experiencing decreases in the quality and quantity of HLA protein produced from their B cell culture process. They have asked the A-Team to identify the root cause of this production problem and propose solutions to increase HLA and B cell yield. The A-Team envisions redesigning cell culture protocols, constructing a system to monitor cell growth in real-time, and implementing new organization systems to promote continuous improvement. Their proposed solution involves characterizing the B cell lines, analyzing current production systems, and collecting data on cell health and growth variables to quantify HLA protein production, staying within a $3,000 cost.
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
This presentation gives an insight into the mammalian cell being used as an expression system, it also includes a brief introduction to the strong promoters.
Production system of biologics
This presentation deals with different types of production system like bacterial,insect,fungal,animal etc.
04 panel05
Molecular pharming uses transgenic animals and plants to produce pharmaceutical proteins. Genes coding for desired proteins are inserted into farm animals so the proteins are expressed in their milk in a continual manner. While transgenic plants are cheap to maintain and easy to propagate, continually harvesting proteins from plants is difficult. The transgenic rubber tree combines advantages of animals and plants by allowing for continual tapping of latex without damage, providing sustained protein production at low cost. Successful molecular pharming still faces challenges in scaling production and ensuring proper protein folding and post-translational modification. The feasibility will depend on matching or improving costs compared to microbial bioreactor production.
Cell lines and maintanence
It contains cell lines and its types and topmost cell lines and criteria for the selection of cell lines
Similar to mRNA Encoded Antibodies (20)
Biotech 2019 - Leveraging Advances in Industrial Biotechnology in the Cellula...
Biotech 2019 - Leveraging Advances in Industrial Biotechnology in the Cellula...
Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...
Host cell protein dynamics in recombinant CHO cells-Impact from harvest to Pu...
Development and strategies of cell-culture technology for influenza vaccine [...
Development and strategies of cell-culture technology for influenza vaccine [...
Hybridoma Technology & its application in fisheries
Hybridoma Technology & its application in fisheries
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
MAMMALIAN CELL EXPRESSION SYSTEM, STRONG PROMOTERS.pptx
More from EchoHan4
ADC conjugate sites analysis
Antibody-drug conjugates employ the specific monoclonal antibodies (mAbs) to achieve targeted delivery of the conjugated cytotoxic molecules to tumor cells.
https://www.creative-biolabs.com/adc/conjugate-sites-analysis.htm
adc chemistry
As one major component of an antibody-drug conjugate (ADC), the antibody is the key for target specificity and serves as the cargo to deliver the cytotoxic drug (payload).
https://www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm
ADC Biotechnology
To retain antibody bioactivity, mild, near-physiological conditions are often used for conjugation reactions. Under these conditions, endogenous amino acids such as Lys and Cys are chemically reactive and can be used as conjugation sites.https://www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm
Antibody Design and Conjugation
As one major component of an antibody-drug conjugate (ADC), the antibody is the key for target specificity and serves as the cargo to deliver the cytotoxic drug (payload). A payload drug can be attached to different sites on an antibody using diverse conjugation chemistry. Multiple endogenous amino acids can serve as potential conjugation sites. However, to achieve more precisely controlled site-directed conjugations and subsequently a narrower distribution of drug-to-antibody ratio (DAR), special moieties with unique conjugation chemistries are engineered into antibody sequences in our antibody design services.
https://www.creative-biolabs.com/adc/antibody-design-and-conjugation.htm
adc cd40
CD40, also known as TNFRSF5, is a type I transmembrane protein. The molecular weight of CD40 is 48-kDa and it consists of a 193 amino acid (aa) extracellular domain, 21 aa leader sequence, 22 aa transmembrane domain, and a 62 aa intracellular domain in human (90 aa in mouse).https://www.creative-biolabs.com/adc/target-cd40-122.htm
ADC Biochemical Analysis
ADC preparation involves the chemical conjugation of the three components and depending on the conjugation strategy used, this process often yields complex and heterogeneous products.https://www.creative-biolabs.com/adc/adc-biochemical-analysis.htm
ADC Antibody Screening
While conventional cancer therapies (surgery, chemo therapy, and radiation therapy) have shown some success in the battle again cancer, they are often accompanied by complex and sometimes, severe side-effects due to the lack of target specificity. To circumvent this flaw and improve the efficacy and safety of cancer treatment, targeted cancer therapies, especially antibody-drug conjugates (ADCs), have been actively exploited and they are gaining a significant amount of attention during the recent years.https://www.creative-biolabs.com/adc/adc-antibody-screening.htm
ADC Affinity Measurement
The elegant design of an antibody-drug conjugate is designated to achieve targeted delivery of the conjugated cytotoxic agents to tumor cells and drug release upon antigen binding and internalization, thus maximizing the antitumor effects while minimizing cytotoxicity to normal tissues. The efficacy of an ADC greatly depends on the specific antigen binding activities of the monoclonal antibody (mAb) portion of the molecule.https://www.creative-biolabs.com/adc/adc-affinity-measurement.htm
5t4 adc
Development of 5T4-based Bispecific ADCs
A bispecific antibody can bind two different targets or two distinct epitopes on the same target. 5T4, specifically overexpressed on the cell surface of various tumors and internalized rapidly when bound to antibody, may be used as an attractive target to develop effective immunotherapy such as bispecific antibody-drug conjugate (ADC).
https://www.creative-biolabs.com/adc/development-of-5t4-based-bispecific-adcs.htm
IND Publishing and Submission
✔ Registration with CTSC
✔ Preparing IND package including Cover letter, IND, 1571, 1572 form and certification form 3674.
✔ Assembling and binding volumes
✔ Submission
https://www.creative-biolabs.com/immuno-oncology/ind-publishing-and-submission.htm
Pre-IND Meeting
For the drug development, pre-IND meeting is a critical tool to discuss the needs and challenges specific to the general product development, nonclinical testing, manufacturing information, protocol design or other regulatory questions defined in the Code of Federal Regulations (21 CFR 312.82). https://www.creative-biolabs.com/immuno-oncology/pre-ind-meeting.htm
Medical Writing and Translation
✔ Clinical overviews (eCTD Module 2.5) including literature review and references
✔ Clinical summaries (eCTD Module 2.7) including clinical pharmacology, efficacy, and safety
✔ Clinical study report preparation and review (eCTD Module 5)
✔ Clinical justification documents for EU, US and other emerging Regulatory markets
✔ Gap analysis for dossiers in clinical module
✔ Clinical and nonclinical document support, handling queries during HA meetings and responding to them
✔ Technical review dossiers
✔ Biowaiver support and justification document services
https://www.creative-biolabs.com/immuno-oncology/medical-writing-and-translation.htm
Regulatory Strategy Consulting
To gain approval for clinical testing after finalizing the pre-clinical testing of innovative new therapies, it is a key milestone for pharmaceutical companies to apply for approval of Investigational New Drug (IND) with FDA or other agencies.https://www.creative-biolabs.com/immuno-oncology/regulatory-strategy-consulting.htm
IND Regulatory Services
Navigating the drug development process from early stage discovery to clinical stage is complex and expensive. https://www.creative-biolabs.com/immuno-oncology/ind-regulatory-services.htm
cGMP Manufacturing
In the United States, the Current Good Manufacturing Practice (cGMP) is the Food and Drug Administration (FDA) 's formal regulations on the design, monitoring, control and maintenance of manufacturing processes and facilities.https://www.creative-biolabs.com/immuno-oncology/cgmp-manufacturing.htm
Antibody and Protein Toxicology
Pre-clinical toxicology is a study of the toxic effects of drugs in development based on statistical and quantitative analysis. https://www.creative-biolabs.com/immuno-oncology/antibody-and-protein-toxicology.htm
Antibody and Protein Pharmacology
Pharmacology is a key component concerned with the study of drug action in animal models which is essential and determinant to IND approval and ultimate NDA approval for a drug candidate. https://www.creative-biolabs.com/immuno-oncology/antibody-and-protein-pharmacology.htm
More from EchoHan4 (20)
Recently uploaded
20240609 QFM020 Irresponsible AI Reading List May 2024
Everything I found interesting about the irresponsible use of machine intelligence in May 2024
Essentials of Automations: The Art of Triggers and Actions in FME
In this second installment of our Essentials of Automations webinar series, we’ll explore the landscape of triggers and actions, guiding you through the nuances of authoring and adapting workspaces for seamless automations. Gain an understanding of the full spectrum of triggers and actions available in FME, empowering you to enhance your workspaces for efficient automation.
We’ll kick things off by showcasing the most commonly used event-based triggers, introducing you to various automation workflows like manual triggers, schedules, directory watchers, and more. Plus, see how these elements play out in real scenarios.
Whether you’re tweaking your current setup or building from the ground up, this session will arm you with the tools and insights needed to transform your FME usage into a powerhouse of productivity. Join us to discover effective strategies that simplify complex processes, enhancing your productivity and transforming your data management practices with FME. Let’s turn complexity into clarity and make your workspaces work wonders!
How to Get CNIC Information System with Paksim Ga.pptx
Pakdata Cf is a groundbreaking system designed to streamline and facilitate access to CNIC information. This innovative platform leverages advanced technology to provide users with efficient and secure access to their CNIC details.
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-und-domino-lizenzkostenreduzierung-in-der-welt-von-dlau/
DLAU und die Lizenzen nach dem CCB- und CCX-Modell sind für viele in der HCL-Community seit letztem Jahr ein heißes Thema. Als Notes- oder Domino-Kunde haben Sie vielleicht mit unerwartet hohen Benutzerzahlen und Lizenzgebühren zu kämpfen. Sie fragen sich vielleicht, wie diese neue Art der Lizenzierung funktioniert und welchen Nutzen sie Ihnen bringt. Vor allem wollen Sie sicherlich Ihr Budget einhalten und Kosten sparen, wo immer möglich. Das verstehen wir und wir möchten Ihnen dabei helfen!
Wir erklären Ihnen, wie Sie häufige Konfigurationsprobleme lösen können, die dazu führen können, dass mehr Benutzer gezählt werden als nötig, und wie Sie überflüssige oder ungenutzte Konten identifizieren und entfernen können, um Geld zu sparen. Es gibt auch einige Ansätze, die zu unnötigen Ausgaben führen können, z. B. wenn ein Personendokument anstelle eines Mail-Ins für geteilte Mailboxen verwendet wird. Wir zeigen Ihnen solche Fälle und deren Lösungen. Und natürlich erklären wir Ihnen das neue Lizenzmodell.
Nehmen Sie an diesem Webinar teil, bei dem HCL-Ambassador Marc Thomas und Gastredner Franz Walder Ihnen diese neue Welt näherbringen. Es vermittelt Ihnen die Tools und das Know-how, um den Überblick zu bewahren. Sie werden in der Lage sein, Ihre Kosten durch eine optimierte Domino-Konfiguration zu reduzieren und auch in Zukunft gering zu halten.
Diese Themen werden behandelt
- Reduzierung der Lizenzkosten durch Auffinden und Beheben von Fehlkonfigurationen und überflüssigen Konten
- Wie funktionieren CCB- und CCX-Lizenzen wirklich?
- Verstehen des DLAU-Tools und wie man es am besten nutzt
- Tipps für häufige Problembereiche, wie z. B. Team-Postfächer, Funktions-/Testbenutzer usw.
- Praxisbeispiele und Best Practices zum sofortigen Umsetzen
HCL Notes and Domino License Cost Reduction in the World of DLAU
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-and-domino-license-cost-reduction-in-the-world-of-dlau/
The introduction of DLAU and the CCB & CCX licensing model caused quite a stir in the HCL community. As a Notes and Domino customer, you may have faced challenges with unexpected user counts and license costs. You probably have questions on how this new licensing approach works and how to benefit from it. Most importantly, you likely have budget constraints and want to save money where possible. Don’t worry, we can help with all of this!
We’ll show you how to fix common misconfigurations that cause higher-than-expected user counts, and how to identify accounts which you can deactivate to save money. There are also frequent patterns that can cause unnecessary cost, like using a person document instead of a mail-in for shared mailboxes. We’ll provide examples and solutions for those as well. And naturally we’ll explain the new licensing model.
Join HCL Ambassador Marc Thomas in this webinar with a special guest appearance from Franz Walder. It will give you the tools and know-how to stay on top of what is going on with Domino licensing. You will be able lower your cost through an optimized configuration and keep it low going forward.
These topics will be covered
- Reducing license cost by finding and fixing misconfigurations and superfluous accounts
- How do CCB and CCX licenses really work?
- Understanding the DLAU tool and how to best utilize it
- Tips for common problem areas, like team mailboxes, functional/test users, etc
- Practical examples and best practices to implement right away
Microsoft - Power Platform_G.Aspiotis.pdf
Revolutionizing Application Development
with AI-powered low-code, presentation by George Aspiotis, Sr. Partner Development Manager, Microsoft
20240607 QFM018 Elixir Reading List May 2024
Everything I found interesting about the Elixir programming ecosystem in May 2024
Full-RAG: A modern architecture for hyper-personalization
Mike Del Balso, CEO & Co-Founder at Tecton, presents "Full RAG," a novel approach to AI recommendation systems, aiming to push beyond the limitations of traditional models through a deep integration of contextual insights and real-time data, leveraging the Retrieval-Augmented Generation architecture. This talk will outline Full RAG's potential to significantly enhance personalization, address engineering challenges such as data management and model training, and introduce data enrichment with reranking as a key solution. Attendees will gain crucial insights into the importance of hyperpersonalization in AI, the capabilities of Full RAG for advanced personalization, and strategies for managing complex data integrations for deploying cutting-edge AI solutions.
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Discover how MongoDB Atlas and vector search technology can revolutionize your application's search capabilities. This comprehensive presentation covers:
* What is Vector Search?
* Importance and benefits of vector search
* Practical use cases across various industries
* Step-by-step implementation guide
* Live demos with code snippets
* Enhancing LLM capabilities with vector search
* Best practices and optimization strategies
Perfect for developers, AI enthusiasts, and tech leaders. Learn how to leverage MongoDB Atlas to deliver highly relevant, context-aware search results, transforming your data retrieval process. Stay ahead in tech innovation and maximize the potential of your applications.
#MongoDB #VectorSearch #AI #SemanticSearch #TechInnovation #DataScience #LLM #MachineLearning #SearchTechnology
UiPath Test Automation using UiPath Test Suite series, part 6
Welcome to UiPath Test Automation using UiPath Test Suite series part 6. In this session, we will cover Test Automation with generative AI and Open AI.
UiPath Test Automation with generative AI and Open AI webinar offers an in-depth exploration of leveraging cutting-edge technologies for test automation within the UiPath platform. Attendees will delve into the integration of generative AI, a test automation solution, with Open AI advanced natural language processing capabilities.
Throughout the session, participants will discover how this synergy empowers testers to automate repetitive tasks, enhance testing accuracy, and expedite the software testing life cycle. Topics covered include the seamless integration process, practical use cases, and the benefits of harnessing AI-driven automation for UiPath testing initiatives. By attending this webinar, testers, and automation professionals can gain valuable insights into harnessing the power of AI to optimize their test automation workflows within the UiPath ecosystem, ultimately driving efficiency and quality in software development processes.
What will you get from this session?
1. Insights into integrating generative AI.
2. Understanding how this integration enhances test automation within the UiPath platform
3. Practical demonstrations
4. Exploration of real-world use cases illustrating the benefits of AI-driven test automation for UiPath
Topics covered:
What is generative AI
Test Automation with generative AI and Open AI.
UiPath integration with generative AI
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Artificial Intelligence for XMLDevelopment
In the rapidly evolving landscape of technologies, XML continues to play a vital role in structuring, storing, and transporting data across diverse systems. The recent advancements in artificial intelligence (AI) present new methodologies for enhancing XML development workflows, introducing efficiency, automation, and intelligent capabilities. This presentation will outline the scope and perspective of utilizing AI in XML development. The potential benefits and the possible pitfalls will be highlighted, providing a balanced view of the subject.
We will explore the capabilities of AI in understanding XML markup languages and autonomously creating structured XML content. Additionally, we will examine the capacity of AI to enrich plain text with appropriate XML markup. Practical examples and methodological guidelines will be provided to elucidate how AI can be effectively prompted to interpret and generate accurate XML markup.
Further emphasis will be placed on the role of AI in developing XSLT, or schemas such as XSD and Schematron. We will address the techniques and strategies adopted to create prompts for generating code, explaining code, or refactoring the code, and the results achieved.
The discussion will extend to how AI can be used to transform XML content. In particular, the focus will be on the use of AI XPath extension functions in XSLT, Schematron, Schematron Quick Fixes, or for XML content refactoring.
The presentation aims to deliver a comprehensive overview of AI usage in XML development, providing attendees with the necessary knowledge to make informed decisions. Whether you’re at the early stages of adopting AI or considering integrating it in advanced XML development, this presentation will cover all levels of expertise.
By highlighting the potential advantages and challenges of integrating AI with XML development tools and languages, the presentation seeks to inspire thoughtful conversation around the future of XML development. We’ll not only delve into the technical aspects of AI-powered XML development but also discuss practical implications and possible future directions.
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
Sudheer Mechineni, Head of Application Frameworks, Standard Chartered Bank
Discover how Standard Chartered Bank harnessed the power of Neo4j to transform complex data access challenges into a dynamic, scalable graph database solution. This keynote will cover their journey from initial adoption to deploying a fully automated, enterprise-grade causal cluster, highlighting key strategies for modelling organisational changes and ensuring robust disaster recovery. Learn how these innovations have not only enhanced Standard Chartered Bank’s data infrastructure but also positioned them as pioneers in the banking sector’s adoption of graph technology.
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
Imagine a world where machines not only perform tasks but also learn, adapt, and make decisions. This is the promise of Artificial Intelligence (AI), a technology that's not just enhancing our lives but revolutionizing entire industries.
Climate Impact of Software Testing at Nordic Testing Days
My slides at Nordic Testing Days 6.6.2024
Climate impact / sustainability of software testing discussed on the talk. ICT and testing must carry their part of global responsibility to help with the climat warming. We can minimize the carbon footprint but we can also have a carbon handprint, a positive impact on the climate. Quality characteristics can be added with sustainability, and then measured continuously. Test environments can be used less, and in smaller scale and on demand. Test techniques can be used in optimizing or minimizing number of tests. Test automation can be used to speed up testing.
Video Streaming: Then, Now, and in the Future
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
Communications Mining Series - Zero to Hero - Session 1
This session provides introduction to UiPath Communication Mining, importance and platform overview. You will acquire a good understand of the phases in Communication Mining as we go over the platform with you. Topics covered:
• Communication Mining Overview
• Why is it important?
• How can it help today’s business and the benefits
• Phases in Communication Mining
• Demo on Platform overview
• Q/A
20240605 QFM017 Machine Intelligence Reading List May 2024
Everything I found interesting about machines behaving intelligently during May 2024
Recently uploaded (20)
20240609 QFM020 Irresponsible AI Reading List May 2024
20240609 QFM020 Irresponsible AI Reading List May 2024
Essentials of Automations: The Art of Triggers and Actions in FME
Essentials of Automations: The Art of Triggers and Actions in FME
How to Get CNIC Information System with Paksim Ga.pptx
How to Get CNIC Information System with Paksim Ga.pptx
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
HCL Notes and Domino License Cost Reduction in the World of DLAU
HCL Notes and Domino License Cost Reduction in the World of DLAU
Full-RAG: A modern architecture for hyper-personalization
Full-RAG: A modern architecture for hyper-personalization
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
Climate Impact of Software Testing at Nordic Testing Days
Climate Impact of Software Testing at Nordic Testing Days
Communications Mining Series - Zero to Hero - Session 1
Communications Mining Series - Zero to Hero - Session 1
20240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 2024
mRNA Encoded Antibodies
- 1. 03-3 Mammalian Cells Today, 60–70% of all recombinant protein pharmaceuticals and 95% of the currently approved therapeutic antibodies are still produced in mammalian cell lines despite relatively high production costs and difficulty in handling. The main reasons for this are the sophisticated folding and secretion machinery as well as the ability to perform post-translational modifications that are not distinguishable from the ones in the human body. However, the risks of contamination by pathogens or bovine spongiform encephalopathy (TSE/BSE) agents have been eliminated by well-documented Good Manufacturing Practice (GMP) compliant designer cell substrates and chemical defined media without the need of supplementing animal serum components. Production yields of recombinant mammalian cell lines quite drastically increased during the past 2 decades (Figure. 3). Over 100-fold improvement in volumetric productivity is due to increased cell densities in modern cell culture processes, but part of it also to improved cell lines with about tenfold higher cell specific productivities. Chinese hamster ovary (CHO) cells are the most common cells applied in the commercial production of biopharmaceuticals. This cell line isolated in the 1950s. Today different genetic progenies have been developed, for example, K1, DukX B11, or DG44 that differ in product quality and yield. Besides this, murine myeloma (NS0, SP2/0), BHK (baby hamster kidney), and HEK293 (human embryonic kidney) are also used to a lesser extent. Although glycosylation patterns of mammalian glycoproteins are very similar to that in humans, even small differences can influence pharmacokinetics and effector functions of antibodies. Alternative designer cell lines with improved glycosylation patterns have been generated.